Suraksha Diagnostic Delivers Robust Q2 FY27 Results with 69% YoY PAT Growth
Suraksha Diagnostic Ltd · Press Release · 10 Nov 2026, 10:46 pm
Suraksha Diagnostic Delivers Robust Q2 FY27 Results with 69% YoY PAT Growth Suraksha Diagnostic reported strong Q2 FY27 performance, with total income rising 26% YoY to ₹1,005.75 million and EBITDA surging 45% YoY to ₹363.17 million as EBITDA margin expanded 500 bps to 36.7%. PAT jumped 69% YoY to ₹149.50 million with a 15.1% margin. Growth was driven by a 12% YoY increase in total patients to 0.42 million and a 19% rise in average revenue per test to ₹427. For H1 FY27, revenue reached ₹1,893.09 million (up 24% YoY) with PAT of ₹277.96 million (up 54% YoY).
Original exchange filing (PDF)
More announcements from Suraksha Diagnostic Ltd
- Intimation of the audio recording of Analysts/Institutional Investors/Organisations meet- ''Earning Call'' for the quarter and half year ended 30 September 2026 · 13 Nov 2026
- Investor Presentation for Quarter and Half Year ended 30 September 2026 Q2 FY 2026-27 · 13 Nov 2026
- Corrigendum to the Press Release - Financial Performance for the Quarter and Half Year ended 30 September 2026 which was initially intimated to Stock Exchange on 10 November 2026 · 13 Nov 2026
- Clarification regarding Non-Publication of Newspaper Advertisement in "Businee Standard" Newspaper of Pune and Ahemdabad region under Regulation 47 of SEBI(LODR) regulation 2015 · 12 Nov 2026
- Corrigendum to the Press Release-Interview published in the Times of India dated November 11,2026 regarding Financial Performance for the Quarter and Half Year ended September 30, 2026 · 11 Nov 2026
- Results-Financial Results for Quarter and Half Year ended 30 September 2026 · 11 Nov 2026
- Outcome of Board Meeting held today i.e. 10th November 2026 · 10 Nov 2026
- Outcome of Board Meeting held today i.e. 10th November 2026 · 10 Nov 2026
